Article
The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.
Human pathology - 1 Jun 2026
Braat Jonathan, Trichy Nithya Sai, Holic Lindsay Jeanne, Olivares Shantel, Bahrami Armita, Balamurugan Thiagarajah, Barnhill Raymond, Blokx Willeke A M, Busam Klaus J, Cerroni Lorenzo, Cook Martin, Duncan Lyn, Elder David, Ferguson Peter, Ferrara Gerardo, Ko Jennifer, Landman Gilles, Lezcano Cecilia, Lowe Lori, Massi Daniela, Mihic-Probst Daniela, Parker Douglas, Sargen Michael, Scolyer Richard, Shea Christopher, Spatz Alan, Tetzlaff Michael, Torres-Cabala Carlos Antonio, Tron Victor, Yeh Iwei, Yun Sook Jung, Zembowicz Artur, Gerami Pedram
Abstract excerpt
BAP1 inactivated melanocytic tumors (BIMTs) are recognized for their potential for significant morphologic atypia including nuclear atypia, expansile growth, and mitotic activity, making it difficult to form firm morphologic criteria for malignancy. Next generation sequencing (NGS) is becoming increasingly utilized in melanocytic pathology. We conducted a two-phase survey with 26 dermatopathologists from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
